Ep 187 - Why Distalmotion’s Roche sees Dexter’s small size as big advantage in the robotics surgical market

Om avsnittet

In this episode of DeviceTalks Weekly, Greg Roche, CEO of Distalmotion, explains why smaller profile surgical robotic systems like Dexter have a shot at competing with established soft tissue giants. Just over two weeks to DeviceTalks Boston register now to meet Roche and other surgical robotics executives! Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.

Ep 187 - Why Distalmotion’s Roche sees Dexter’s small size as big advantage in the robotics surgical market

Om avsnittet

Fler avsnitt

Ep 304 - J&J MedTech's Polyphonic Lead Explains Why Surgical Intelligence Is the Next Big Shift in the OR

Ep 303 - Xeltis CEO Schutte on Building a Business Around Tech that Helps the Body Build New Blood Vessels

Ep 302 - Inner Logic CEO Porras explains how autonomous surgery can save us from looming surgeon shortage

Ep 301 - Medtronic’s Grubb on Bringing a Structuralist Perspective to a Growing Structural Heart Portfolio

Ep 300 - How Mobia Medical’s Stroke Recovery Mission Muscled It Past MedTech’s Public Market Malaise

Ep 299 - Surgical Robotics Recap: Steve Bell on SRS, Karl Storz’s Gaudet and Sovato CEO Brian Miller

Ep 298 - Is Fractyl poised to create a new MedTech market by helping former GLP-1 users keep weight off?

Ep 297 - J&J MedTech’s Devi Govender wants to change the lives – and the language – of heart recovery patients

Ep 296 - XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution

Ep 295 - Can Calyxo CEO Catanese Lead New Company Down Familiar Tract to Build Another Urology Powerhouse